Role of bone scans in the initial assessment of operable patients with breast carcinoma
Abstract
The yield and the prognostic significance of initially performed bone scintigraphy in 387 patients with operable mammary carcinoma are reported. The mean follow-up time was 52 months. In 12 patients (3.1%) the scintigraphy was considered to indicate bone metastases but in only 3 of these bone metastases later developed. The low information obtained has resulted in exclusion of bone scintigraphy in the initial assessment of clinically operable patients with mammary carcinoma.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 387 participants or records.
Read the paper
Related studies
- Benign periarticular, bone and joint lipomatous lesions
- A review of the physiological and histological effects of laser osteotomy
- Quality of bone healing: perspectives and assessment techniques
- Effects of bioactive lipids and lipoproteins on bone
- Bone structure and function
- Quantifying bone structure, micro-architecture, and pathophysiology with MRI.
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.